Group Vice President and General Manager, Rheumatology Business Unit
Mr. Karnani joined Horizon Pharma in July 2014 as group vice president and general manager, specialty business unit. Prior to joining Horizon, Mr. Karnani was with Fresenius Kabi, a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition, where he served as Vice President of the Therapeutics and Cell Therapy business, with a focus on sales, marketing and clinical implementation. Mr. Karnani also held various positions in business development, corporate strategy and strategic marketing within Fenwal Inc., a private equity owned global medical device company, that was acquired by Fresenius Kabi.
Mr. Karnani brings nearly 16 years of cross functional expertise across a multitude of industries, including medical devices, management consulting, semiconductors and cellular telecommunications.
Mr. Karnani has an MBA from the Kellogg School of Management at Northwestern University, a master’s degree in Electrical Engineering from Case Western Reserve University, and a bachelor’s degree in Electrical Engineering from University of Bombay, India.